The relationship between the month of birth and ADHD treatment

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS18732
• Study ID:
  41916
• Official title and acronym:
  The relationship between the month of birth and ADHD treatment
• DARWIN EU® study:
  No
• Study countries:
  Netherlands
• Study description:
  ****This study has been cancelled before data collection due to lack of time by the researchers**** There seems to be a relationship between a child’s month of birth and the diagnosis and treatment of attention deficit hyperactivity disorder (ADHD). Both underdiagnosis as well as overdiagnosis of ADHD can have consequences for the future of a child. The objective of this study is to determine if there is a relationship between the month of birth and the pharmacological treatment of ADHD in children in the Netherlands. The study cohort includes children and adolescents ≤ 24 years old who use ADHD medication, dispensed for the first time between 2006-2016.
• Study status:
  Finalised

Research institutions and networks

Institutions

Division of Pharmacoepidemiology & Clinical Pharmacology (PECP), Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University

Netherlands

Study timelines

Date when funding contract was signed

Planned:01/02/2017

Actual:01/02/2017

Study start date

Planned:01/06/2017

Actual:01/06/2017

Date of final study report

Planned:01/01/2018

Actual:07/07/2021

Sources of funding

Other

More details on funding

Division of Pharmacoepidemiology & Clinical Pharmacology

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable